Therefore, the enhanced CK14+CK8+ bi-lineage progenitor cell population in MUT-PyMT mammary tissue may account for the poorly differentiated, tamoxifen resistant MUT-PyMT tumor phenotype. This evidence concerns the gene KRT8 and neoplasm.